Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9628 posts found.

Sofinnova and AWS collaborate on AI tools for life sciences

June 10, 2026 Research and Development AI, Amazon Web Services (AWS), Sofinnova

Sofinnova Partners has announced a collaboration with Amazon Web Services (AWS) aimed at expanding the use of AI across life …
News

First European approval given to non-opioid treatment for chronic low back pain

June 9, 2026 Research and Development low back pain, non-opioid treatment

Germany has granted marketing authorisation to Exilby (VER-01) for the treatment of chronic low back pain with a neuropathic component, …
News

Phase 2 study explores imaging approach for interstitial lung disease

June 5, 2026 Research and Development interstitial lung disease

Serac Healthcare has presented phase 2 data suggesting its investigational imaging agent, 99mTc-maraciclatide, may help distinguish active inflammation from fibrosis …
News

Laverock secures funding for gene-control platform development

June 4, 2026 Research and Development Laverock Therapeutics

Laverock Therapeutics has been awarded more than £2.2m in grant funding to support development of its gene-control platform and expand …
News

LifeArc and Elpida partner to advance gene therapies for ultra-rare childhood diseases

June 3, 2026 Research and Development gene therapies

LifeArc has announced a partnership with Elpida Therapeutics to support development of gene therapies for three ultra-rare neurodegenerative diseases affecting …
News

Well Pharmacy and Alzheimer’s Society launch dementia partnership

June 2, 2026 Research and Development dementia

Well Pharmacy has announced a partnership with Alzheimer’s Society aimed at improving support for people living with dementia and their …
News
drug-trials

MHRA authorises donidalorsen for hereditary angioedema prevention

May 27, 2026 Research and Development donidalorsen

Otsuka Pharmaceuticals UK announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has authorised Dawnzera (donidalorsen) for routine prevention …
News

BioDuro and CTI Biotechnology in preclinical drug development partnership

May 21, 2026 Research and Development BioDuro, CTI Biotechnology

BioDuro has announced a strategic partnership with CTI Biotechnology. The collaboration will leverage the complementary strengths of both companies across critical stages …
News

Study explores genomic testing approach for unexplained infertility

May 14, 2026 Research and Development infertility

Researchers across the Asia Pacific region have reported findings from a study investigating whether long-read whole genome sequencing could improve …
News

Synnovis and SOPHiA GENETICS expand liquid biopsy testing in NHS cancer care

May 13, 2026 Research and Development Sophia Genetics, Synnovis

Synnovis and SOPHiA GENETICS have announced a collaboration to expand blood-based cancer testing for patients with lung and breast cancer …
News

Syngene appoints Maninder Kapoor Puri as CHRO

May 6, 2026 Research and Development Syngene International

Syngene International, a global contract research, development, and manufacturing organization (CRDMO), has announced the appointment of Maninder Kapoor Puri as …
Appointment

Syngene appoints Abhijit Zutshi as CCO

May 5, 2026 Research and Development Syngene International

Syngene International, a global contract research, development, and manufacturing organization (CRDMO), has announced the appointment of Abhijit Zutshi as Chief …
Appointment

Study suggests phospholipid therapy may impact fatty liver disease outcomes

April 29, 2026 Research and Development fatty liver disease, phospholipid therapy

A randomised clinical trial has reported that treatment with essential phospholipids (Essentiale) may reduce liver fat and improve symptoms in …
News

New web series explores path from ophthalmic research to patient access

April 28, 2026 Research and Development Opthalmology

A new YouTube web series has been launched to examine how ophthalmic innovations progress from early research through to approved …
News

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026 Research and Development The European Medicines Agency (EMA), plozasiran

The European Medicines Agency (EMA) has recommended granting a marketing authorisation for Redemplo (plozasiran) to treat adults with familial chylomicronaemia …
News
The Gateway to Local Adoption Series

Latest content

NICE backs atogepant for acute migraine treatment

June 12, 2026

Survey data highlight challenges in anaphylaxis treatment adherence

June 11, 2026

Hansa Biopharma appoints Fredrik Röök as VP Business Development

June 11, 2026

Sofinnova and AWS collaborate on AI tools for life sciences

June 10, 2026

First European approval given to non-opioid treatment for chronic low back pain

June 9, 2026